Parkman Healthcare Partners LLC

CIK 1777015 · View on SEC EDGAR ↗

Portfolio value QoQ: +0.7% 13F does not disclose cash

Top 10 holdings weight33.49%

Top 25 holdings weight63.56%

Positions above 1%40

Effective number of positions46.7

Based on 13F long-equity holdings only (cash, bonds, shorts not disclosed)

Turnover Q2 2026: 28.35% Est. buys $275,892,837 · sells $361,801,571

Median holding: 3.0 quarters Tracked Q1 2025–Q2 2026 · 45.6% still held

New positions18

Increased27

Decreased30

Closed30

Put-notional exposure: 0.3% puts 13F reports option positions at underlying notional value — may include hedges, not necessarily bearish bets

Portfolio value $976.8M #2,595 of 9,339 by 13F value · top 27.8%

Positions 77

As of June 30, 2026 Data as of Q2 2026

Performance vs S&P 500

Tracked Q1 2025–Q2 2026 +40.5%

S&P 500 total return (same window) +37.0%

Excess return +3.5%

Annualized: +31.2% · S&P 500: +28.7%

Approximates a buy-and-hold portfolio built from quarterly SEC 13F snapshots. Excludes cash, short positions, options/derivatives, and non-13(f) securities — reflects the disclosed long-equity book only, not total fund AUM. SEC filing lag is up to 45 days; this is not a real-time-copyable timing.

Priceable coverage: 97.3% · Options excluded: 1.3%

Sector breakdown

Healthcare 98.8%

Other/Unmapped 1.2%

Full portfolio 77 positions

				Type		Streak
MBX MBX Biosciences, Inc. - Common Stock	$44,169,550	4.52%	800,173		$20,288,446	Up ×1
LLY Eli Lilly and Company Common Stock	$41,980,050	4.30%	35,000		$10,141,292	Up ×1
CVS CVS Health Corporation Common Stock	$40,530,779	4.15%	391,791		$12,714,462	Up ×1
DXCM DexCom, Inc. - Common Stock	$36,016,557	3.69%	534,767		$-7,304,265	Down ×1
PTCT PTC Therapeutics, Inc. - Common Stock	$35,539,315	3.64%	435,691		$6,150,486	Up ×2
RCUS Arcus Biosciences, Inc. Common Stock	$28,340,971	2.90%	919,266		$2,263,853	Down ×1
GPCR Structure Therapeutics Inc. - American Depositary Shares	$26,065,426	2.67%	485,661		$14,878,543	Up ×2
VRDN Viridian Therapeutics, Inc. - Common Stock	$25,306,071	2.59%	1,377,576		$14,392,843	Up ×1
AGIO Agios Pharmaceuticals, Inc. - Common Stock	$24,828,297	2.54%	669,046		$11,177,046	Up ×2
INBX Inhibrx Biosciences, Inc. - Common Stock	$24,346,013	2.49%	256,950			Up ×1
XENE Xenon Pharmaceuticals Inc. - Common Shares	$23,985,796	2.46%	397,379		$-4,916,789	Down ×1
EWTX Edgewise Therapeutics, Inc. - Common Stock	$23,444,973	2.40%	577,036		$13,275,891	Up ×1
UNH UnitedHealth Group Incorporated Common Stock (DE)	$23,242,445	2.38%	55,921
SYK Stryker Corporation Common Stock	$21,400,619	2.19%	67,973		$-29,455,584	Down ×1
IQV IQVIA Holdings, Inc. Common Stock	$20,444,801	2.09%	105,811		$5,658,642	Up ×3
ZBH Zimmer Biomet Holdings, Inc. Common Stock	$20,020,832	2.05%	232,557		$-4,352,512	Down ×1
PODD Insulet Corporation - Common Stock	$20,002,301	2.05%	131,378		$-12,850,459	Down ×1
ASMB Assembly Biosciences, Inc. - Common Stock	$19,818,054	2.03%	721,181		$8,406,505	Up ×2
SNDX Syndax Pharmaceuticals, Inc. - Common Stock	$19,176,816	1.96%	877,256		$-1,882,481	Down ×1
EYPT EyePoint, Inc. - Common Stock	$18,420,731	1.89%	1,288,163		$957,359	Down ×1
THC Tenet Healthcare Corporation Common Stock	$18,199,142	1.86%	97,280		$8,740,431	Up ×1
LIVN LivaNova PLC - Ordinary Shares	$17,311,800	1.77%	210,529		$-8,364,215	Down ×2
ANIP ANI Pharmaceuticals, Inc. - Common Stock	$16,796,641	1.72%	202,907		$-4,779,577	Down ×1
BCRX BioCryst Pharmaceuticals, Inc. - Common Stock	$16,242,790	1.66%	1,624,279		$-18,312	Down ×1
ALNY Alnylam Pharmaceuticals, Inc. - Common Stock	$15,253,792	1.56%	50,672		$6,348,095	Up ×1
INDV Indivior Pharmaceuticals, Inc. - Common Stock	$14,945,957	1.53%	364,269			Up ×1
NVST Envista Holdings Corporation Common Stock	$14,595,687	1.49%	553,916		$-3,459,964	Down ×1
DRUG Bright Minds Biosciences Inc. - common stock	$14,394,721	1.47%	205,053		$11,468,770	Up ×1
XERS Xeris Biopharma Holdings, Inc. - Common Stock	$14,316,358	1.47%	1,807,621		$4,333,027	Up ×2
AVTX Avalo Therapeutics, Inc. - Common Stock	$14,161,039	1.45%	766,290			Up ×1
FDMT 4D Molecular Therapeutics, Inc. - Common Stock	$12,610,847	1.29%	948,184		$7,745,655	Up ×3
IMNM Immunome, Inc. - Common Stock	$12,591,140	1.29%	594,202		$3,766,879	Up ×2
STOK Stoke Therapeutics, Inc. - Common Stock	$11,630,095	1.19%	355,443		$673,036	Up ×1
WAT Waters Corporation Common Stock	$11,328,458	1.16%	30,206		$3,452,541	Up ×1
ANRO Alto Neuroscience, Inc. Common Stock	$11,322,234	1.16%	429,035			Up ×1
ORKA Oruka Therapeutics, Inc. - Common Stock	$10,772,102	1.10%	113,188			Up ×1
ADPT Adaptive Biotechnologies Corporation - Common Stock	$10,445,807	1.07%	486,984		$2,786,615	Down ×1
ABSI Absci Corporation - Common Stock	$10,365,795	1.06%	894,374		$4,771,377	Down ×1
MLYS Mineralys Therapeutics, Inc. - Common Stock	$10,261,951	1.05%	380,354		$-35,960	Up ×1
COGT Cogent Biosciences, Inc. - Common Stock	$9,805,226	1.00%	253,365		$5,951,376	Up ×1
QURE uniQure N.V. - Ordinary Shares	$9,588,310	0.98%	208,170		$6,206,443	Up ×1
TARS Tarsus Pharmaceuticals, Inc. - Common Stock	$9,441,000	0.97%	150,000			Up ×1
AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock	$9,367,999	0.96%	541,190		$5,629,652	Up ×1
IRTC iRhythm Holdings, Inc. - Common Stock	$8,001,410	0.82%	67,267		$3,265,857	Up ×1
CYRX CryoPort, Inc. - Common Stock	$7,980,687	0.82%	508,324			Up ×1
BSX Boston Scientific Corporation Common Stock	$7,702,929	0.79%	180,481		$-20,457,263	Down ×2
CLYM Climb Bio, Inc. - Common Stock	$7,347,831	0.75%	563,484			Up ×1
AMLX Amylyx Pharmaceuticals, Inc. - Common Stock	$7,162,125	0.73%	398,782		$-1,476,141	Down ×1
UPB Upstream Bio, Inc. - Common Stock	$6,471,909	0.66%	935,247		$-609,138	Up ×1
RMD ResMed Inc. Common Stock	$6,427,727	0.66%	32,983
URGN UroGen Pharma Ltd. - Ordinary Shares	$6,405,555	0.66%	174,064		$1,461,055	Down ×1
ALGN Align Technology, Inc. - Common Stock	$6,234,180	0.64%	36,963		$2,594,207	Up ×1
CARL Carlsmed, Inc. - Common Stock	$6,200,161	0.63%	597,318		$1,483,998	Up ×1
AVAH Aveanna Healthcare Holdings Inc. - Common Stock	$6,122,845	0.63%	714,451			Up ×1
CDNA CareDx, Inc. - Common Stock	$5,768,885	0.59%	202,417		$710,563	Down ×1
SIBN SI-BONE, Inc. - Common Stock	$5,364,156	0.55%	328,686		$646,182	Down ×3
VIR Vir Biotechnology, Inc. - Common Stock	$4,843,093	0.50%	475,279		$363,093	Down ×1
ERAS Erasca, Inc. - Common Stock	$4,739,091	0.49%	258,684		$-1,841,347	Down ×1
SI Shoulder Innovations, Inc. Common Stock	$4,587,579	0.47%	226,212			Up ×1
WAY Waystar Holding Corp. - Common Stock	$4,187,833	0.43%	203,986		$-6,494,295	Down ×1
ATEC Alphatec Holdings, Inc. - Common Stock	$3,892,007	0.40%	449,943		$-5,070,534	Down ×1
ANNX Annexon, Inc. - common stock	$3,660,276	0.37%	641,029		$-73,756	Down ×1
CSTL Castle Biosciences, Inc. - Common stock	$3,453,265	0.35%	144,791		$356,282	Up ×1
Unknown issuer (CUSIP: 60365F109)	$3,385,368	0.35%	226,446		$-1,349,106	Down ×1
EIKN Eikon Therapeutics, Inc. - Common Stock	$3,341,492	0.34%	256,053			Up ×1
VTRS Viatris Inc. - Common Stock	$3,176,000	0.33%	200,000			Up ×1
Unknown issuer (CUSIP: 384747951)	$3,140,420	0.32%	46,000	Put option		Up ×1
AORT Artivion, Inc. Common Stock	$3,121,982	0.32%	138,940		$-6,106,771	Down ×1
AXSM Axsome Therapeutics, Inc. - Common Stock	$2,447,700	0.25%	10,000			Up ×1
OPRX OptimizeRx Corporation - Common Stock	$2,003,985	0.21%	350,347		$-2,576,452	Down ×1
NSPR InspireMD Inc. - Common Stock	$1,691,804	0.17%	2,416,518		$-2,247,120
Unknown issuer (CUSIP: 423494103)	$1,652,850	0.17%	45,000			Up ×1
LUNG Pulmonx Corporation - Common Stock	$840,533	0.09%	646,564		$-134,237	Down ×1
SPRY ARS Pharmaceuticals, Inc. - Common Stock	$822,627	0.08%	102,700			Up ×1
EDAP EDAP TMS S.A. - American Depositary Shares, each representing One Ordinary Share	$802,030	0.08%	154,832		$226,055
OVID Ovid Therapeutics Inc. - Common Stock	$532,477	0.05%	197,947		$70,262	Down ×1
ENTX Entera Bio Ltd. - Ordinary Shares	$485,860	0.05%	274,497		$165,436	Down ×1
No matches

Conviction holdings

Positions increased for 3+ consecutive quarters.

Share counts are as reported in 13F filings (not split-adjusted)

Security	Value	% of portfolio	Streak
IQV	$20,444,801	2.09%	up ×3
FDMT	$12,610,847	1.29%	up ×3

Biggest new bets

New positions opened this quarter, largest first.

Security	Value	Shares	% of portfolio
INBX	$24,346,013	256,950	2.49%
UNH	$23,242,445	55,921	2.38%
INDV	$14,945,957	364,269	1.53%
AVTX	$14,161,039	766,290	1.45%
ANRO	$11,322,234	429,035	1.16%
ORKA	$10,772,102	113,188	1.10%
TARS	$9,441,000	150,000	0.97%
CYRX	$7,980,687	508,324	0.82%
CLYM	$7,347,831	563,484	0.75%
RMD	$6,427,727	32,983	0.66%
AVAH	$6,122,845	714,451	0.63%
SI	$4,587,579	226,212	0.47%
EIKN	$3,341,492	256,053	0.34%
VTRS	$3,176,000	200,000	0.33%
Unknown issuer (CUSIP: 384747951)	$3,140,420	46,000	0.32%

Top movers (QoQ)

Security	Action	Shares Δ	Value Δ
SYK	Trimmed	-87K	-$29.5M
BSX	Trimmed	-268K	-$20.5M
MBX	Bought more	+136	+$20.3M
GPCR	Bought more	+254K	+$14.9M
VRDN	Bought more	+820K	+$14.4M
EWTX	Bought more	+254K	+$13.3M
PODD	Trimmed	-25K	-$12.9M
CVS	Bought more	+4K	+$12.7M
DRUG	Bought more	+165K	+$11.5M
AGIO	Bought more	+266K	+$11.2M

Exited positions

Includes corporate events (mergers, delistings) — not all exits are sells

Closed positions reflect 13F reporting changes; for index managers these are often mechanical (delisting, M&A, index rebalancing), not active decisions.

Security	Quarter	Shares before	Value before	Price since exit
QQQ	Dec. 31, 2025	80,000	$48,029,600	21.2%
KALV	June 30, 2026	1,835,506	$36,948,736	No longer tracked
BDX	June 30, 2025	120,283	$27,552,024
UNH	June 30, 2025	50,213	$26,299,059	34.0%
MASI	March 31, 2026	200,000	$26,012,000	No longer tracked
TERN	March 31, 2026	620,877	$25,083,431	No longer tracked
QGEN (filed as QGENXXXX)	March 31, 2026	494,351	$22,230,964	25.8%
FOLD	March 31, 2026	1,487,283	$21,178,910	No longer tracked
QGEN	June 30, 2026	500,000	$20,020,000	28.9%
VRNA	Sept. 30, 2025	197,898	$18,717,193	No longer tracked
ABBV	June 30, 2026	75,000	$16,311,750	13.5%
MTD	March 31, 2026	10,988	$15,319,360	32.4%
RVTY	Sept. 30, 2025	157,196	$15,203,997	81.1%
GILD	Sept. 30, 2025	131,675	$14,598,807	40.6%
A	March 31, 2026	100,000	$13,607,000	51.8%
ILMN	June 30, 2026	110,370	$13,604,206	53.2%
DHR	March 31, 2026	58,889	$13,480,870	21.6%
EW	June 30, 2026	167,155	$13,385,772	-1.5%
NBIX	June 30, 2026	99,069	$13,051,350	-15.3%
KNSA	June 30, 2026	259,184	$12,479,710	20.0%
MCK	June 30, 2026	12,676	$10,969,303	32.4%
UNH	March 31, 2026	31,875	$10,522,256	54.5%
UTHR	Dec. 31, 2025	22,000	$9,222,620	20.6%
NUVL	June 30, 2026	88,078	$9,023,591	No longer tracked
AXGN	June 30, 2026	268,160	$8,884,141	-17.6%
MRUS	Sept. 30, 2025	162,980	$8,572,748	No longer tracked
INCY	Dec. 31, 2025	100,442	$8,518,486	17.2%
IDXX	June 30, 2026	15,000	$8,428,350	6.4%
ANIP	Sept. 30, 2025	128,478	$8,383,190	-20.7%
ACLX	March 31, 2026	128,111	$8,352,837	No longer tracked
REPL	Sept. 30, 2025	896,710	$8,330,436	173.5%
ASND	Dec. 31, 2025	40,343	$8,020,592	14.1%
LLY	Dec. 31, 2025	10,000	$7,630,000	18.5%
DGX	Sept. 30, 2025	40,997	$7,364,291	26.9%
DOCS	March 31, 2026	162,276	$7,185,581	43.3%
BMRN	Dec. 31, 2025	125,949	$6,821,398	-5.9%
APGE	June 30, 2026	77,686	$6,538,831	No longer tracked
COO	June 30, 2026	89,883	$6,426,635	-14.6%
OM	Dec. 31, 2025	454,512	$6,417,709	10.5%
BIIB	March 31, 2026	35,425	$6,234,446	36.7%
DAWN	March 31, 2026	645,544	$6,016,470	No longer tracked
ALKS	Sept. 30, 2025	200,000	$5,722,000	45.4%
TNGX	June 30, 2026	266,127	$5,567,377	-25.3%
TMDX	March 31, 2026	45,174	$5,495,417	-28.8%
SDGR	March 31, 2026	298,939	$5,345,029	109.5%
VERA	March 31, 2026	100,564	$5,092,561	-30.4%
RMD	June 30, 2025	22,622	$5,063,935	-2.0%
RARE	June 30, 2026	235,000	$4,923,250	-53.1%
PHLT	Sept. 30, 2025	1,214,272	$4,857,088	No longer tracked
ABVX	Dec. 31, 2025	55,197	$4,686,225	-34.7%
SUPN	June 30, 2026	85,062	$4,396,855	-12.5%
PGEN	March 31, 2026	1,002,826	$4,191,813	59.9%
CAI	June 30, 2026	229,912	$4,110,827	79.6%
SYRE	March 31, 2026	124,485	$4,078,129	79.1%
CVRX	June 30, 2026	429,507	$4,063,136	-72.4%
GH	June 30, 2025	89,329	$3,805,415	224.9%
MNKD	March 31, 2026	640,356	$3,630,819	30.2%
PCVX	June 30, 2025	93,431	$3,527,955	85.9%
TVTX	March 31, 2026	86,297	$3,297,408	68.6%
WGS	June 30, 2026	50,778	$3,260,963	-18.2%
VCYT	June 30, 2026	101,237	$3,260,844	-18.4%
CERT	March 31, 2026	348,750	$3,072,488	81.2%
CMPS	June 30, 2026	554,411	$3,065,893	-21.0%
INSM	June 30, 2025	37,901	$2,891,467	-7.2%
DVAX	Dec. 31, 2025	271,306	$2,694,069	No longer tracked
NRIX	Sept. 30, 2025	228,271	$2,600,007	174.2%
TVRD	Dec. 31, 2025	65,000	$2,533,050	-78.1%
PTGX	March 31, 2026	25,973	$2,268,482	31.3%
SLDB	June 30, 2026	308,844	$2,223,677	-40.7%
KROS	June 30, 2025	217,753	$2,218,903	-15.5%
BFLY	June 30, 2026	544,477	$2,199,687	-19.7%
NAMS	June 30, 2025	100,955	$2,066,549	8.8%
QDEL	June 30, 2026	101,764	$1,671,983	-21.6%
ICAD	June 30, 2025	781,670	$1,610,240	No longer tracked
RXST	June 30, 2026	249,989	$1,539,932	4.1%
MRVI	June 30, 2025	660,000	$1,458,600	203.7%
ACHC	March 31, 2026	100,000	$1,419,000	34.7%
INSP	March 31, 2026	15,000	$1,383,450	37.9%
QTRX	June 30, 2026	341,453	$1,201,915	-33.8%
ARDX	Sept. 30, 2025	301,086	$1,180,257	-44.1%
SENS	March 31, 2026	206,793	$1,141,497	12.8%
SLN	June 30, 2025	401,746	$1,132,924	239.1%
ORIC	June 30, 2025	203,006	$1,132,773	29.8%
PLSE	June 30, 2026	50,125	$1,082,199	91.2%
CRNX	March 31, 2026	22,852	$1,063,761	No longer tracked
RPID	March 31, 2026	354,465	$1,027,949	-65.6%
MAZE	June 30, 2026	31,844	$950,543	3.9%
MASS	Dec. 31, 2025	100,368	$879,224	118.9%
MDLN	March 31, 2026	20,558	$863,436	-23.4%
ATYR	Sept. 30, 2025	150,000	$760,500	-77.1%
ADMA	June 30, 2026	82,443	$742,811	27.6%
RLAY	June 30, 2025	188,052	$492,696	425.4%
TMCI	March 31, 2026	199,393	$488,513	218.7%
VYNE	June 30, 2025	217,978	$344,405	No longer tracked
ARAY	June 30, 2026	884,578	$343,305	-50.0%
IRWD	June 30, 2025	205,086	$301,476	380.6%

Person profile: Parkman Healthcare Partners LLC